GlassScriptPhysician profile
Karin S Maddox
NPI 1780644997
$7,212.58
in general payments reported to CMS, 2019-2025
49 companies · $2,070 in 2025
The $2,070 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $537 · 2021: $1,063 · 2022: $758 · 2023: $989 · 2024: $1,387 · 2025: $2,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,447.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,110.43 | 2021-2025 | |
| Pfizer INC. | $639.24 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $503.45 | 2019-2025 | |
| Ucb, INC. | $358.58 | 2021-2025 | Zilbrysq, Briviact, Rystiggo |
| Jazz Pharmaceuticals INC. | $353.44 | 2019-2025 | Xywav |
| Lilly USA, LLC | $345.28 | 2019-2025 | Kisunla, Emgality, Amyvid |
| Amgen INC. | $339.78 | 2019-2022 | |
| Sk Life Science, INC. | $331.57 | 2020-2025 | Xcopri |
| Biogen, INC. | $288.11 | 2019-2025 | Vumerity |
| Teva Pharmaceuticals USA, INC. | $245.36 | 2019-2022 | |
| Mdd US Operations, LLC | $242.38 | 2023-2025 | Gocovri, Gocovri |
| Acadia Pharmaceuticals INC | $225.17 | 2019-2025 | Nuplazid |
| Genzyme Corporation | $185.59 | 2019-2025 | |
| Genentech USA, INC. | $151.96 | 2022-2025 | Ocrevus Zunovo, Ocrevus |
| Argenx US, INC. | $132.95 | 2024-2025 | Vyvgart Hytrulo |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Maddox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.